Estimating resource needs and gaps for harm reduction in Asia

Similar documents
Harm reduction in Asia: progress towards universal access to harm reduction services among people who inject drugs

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009

HARM REDUCTION IN ASIA. Adeeba Kamarulzaman University of Malaya, Kuala Lumpur

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

AIDS Funding Landscape in Asia and the Pacific

Technical Guidance Note for Global Fund HIV Proposals

Tracking the HIV/AIDS epidemic in

China Country Advocacy Brief Injecting Drug Use and HIV

Cambodia Country Advocacy Brief Injecting Drug Use and HIV

Getting to zero HIV new infections in Asia and the Pacific region: Possible or impossible dream?

Ending the AIDS epidemic by 2030

Harm Reduction in Nigeria

1/5 of world s population 40% of world s poor 400 million < USD 1/day >11 million drug users & > 3.6 million opiate users

Drug Use, Prisons and Compulsory Drug Treatment Centers

Fifth National Conference on AIDS

Program to control HIV/AIDS

Collaborative TB and HIV Services for People Who Use Drugs

ASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030

In 2013, around 12.9 million people living with HIV had access to antiretroviral therapy.

Review of new NSPs in Asia and the Pacific Region

A Data Use Guide ESTIMATING THE UNIT COSTS OF HIV PREVENTION OF MOTHER-TO-CHILD TRANSMISSION SERVICES IN GHANA. May 2013

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

India Country Advocacy Brief Injecting Drug Use and HIV

Bangladesh Country Advocacy Brief Injecting Drug Use and HIV

aids in asia and the pacific

Tuberculosis-related deaths in people living with HIV have fallen by 36% since 2004.

Population. B.3. HIV and AIDS. There has been mixed progress in reducing new HIV infections and AIDSrelated

26 28 May 2010, Almaty, Kazkhstan. Nina Kerimi UNODC Regional Project Coordinator 1

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

Towards universal access

GLOBAL STATISTICS FACT SHEET 2015

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific

The Goals Model as a Tool for Allocating HIV/AIDS Resources & Strategic Planning

Bangladesh United Nations Regional Task Force on Injecting Drug Use and HIV/AIDS in Asia and the Pacific Baseline Assessment Dec 2006

Leaving no one behind in Asia and the Pacific. Steven J. Kraus Director UNAIDS Regional Support Team, Asia and the Pacific 28 th January 2015

HIV / AIDS & HUMAN RIGHTS

4th Asian Academic Society International Conference (AASIC) 2016 HEA-OR-095

Rapid Assessment of Sexual and Reproductive Health

HIV Resource Allocations using AEM

Progress, challenges and the way forward in ASEAN Member States

Age of Consent as a Policy Barrier: Implications and Future Directions for Prevention in the East Asia/Pacific Region

World Health Organization. A Sustainable Health Sector

COMPARATIVE ANALYSIS OF SEXUAL AND DRUG USE BEHAVIOUR AND HIV KNOWLEDGE OF YOUNG PEOPLE IN ASIA AND THE PACIFIC Anne Bergenstrom Pimonpan Isarabhakdi

Myanmar United Nations Regional Task Force on Injecting Drug Use and HIV/AIDS in Asia and the Pacific Baseline Assessment Dec 2006 ACRONYMS - MYANMAR

in East Asia and the Pacific

Place matters: why cities are key to ending AIDS

An assessment report on gender integration gaps and opportunities within KHANA s harm reduction program in Cambodia

SCALING UP TOWARDS UNIVERSAL ACCESS

REPORT SECOND SIDA PROJECT ADVISORY COMMITTEE MEETING November 2008 Manila, Philippines. Convened by

FINANCING FRAMEWORK: RESOURCE REQUIREMENT for the KENYA NATIONAL AIDS STRATEGIC PLAN (KNASP)

COUNTRY TABLE. MONTENEGRO.

TB Disease Prevalence Survey - Progress Report

New Delhi International Ministerial Conference on Avian and Pandemic Influenza Dec 4-6th, 2007

OIE Regional initiatives for rabies control

Intervention from the World Health Organization

Updated Resource Requirements for Sustainable Financing of the HIV Response in Indonesia

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision

KAZAKHSTAN. National Focal Point. Drug Abuse and Drug Dependence Treatment Situation. Territory : 2,717,300 km 2 Capital: Astana BASIC DATA

SDG Target 16.1 Measuring the prevalence of physical, psychological and sexual violence

Challenges and Opportunities for Responding to HIV/AIDS in LDCs. Mazuwa Banda Department of HIV/AIDS World Health Organization

Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries

Tajikistan National Report. Summary HARM REDUCTION WORKS FUND IT! Arguments for strategic investment. Summary of National Report: Tajikistan

In or Out? Asia-Pacific Review of Young Key Populations in National AIDS Strategic Plans SOURCE METRICS PARTNERSHIPS GOAL RESULTS DATA TARGET LINKS

Myanmar national study on the socioeconomic impact of HIV on households

The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America

Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control

Version for the Silent Procedure 29 April Agenda item January Hepatitis

Improving NSP and Harm Reduction Services. Jason Farrell, European HCV and Drug Use Initiative

Ending the AIDS Epidemic in Adolescents

HIV AND PEOPLE WHO INJECT DRUGS

HIV Situation in South-East Asia. HIV unit Department of Communicable Diseases

Effects of the Global Fund on the health system

STI and HIV Prevention and Care among Sex Workers

SOUTH ASIA HIV PROGRAMME ( ) Red Cross and Red Crescent Global Alliance on HIV

2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030

Options for meeting Myanmar s commitment to achieving MDG 5

who inject drugs THE GAP REPORT 2014

Global TB control: Current status with particular attention to TB among women and children

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific

Hepatitis and HIV Co-Infection: Situation in Ukraine.

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs,

HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres

Briefing. Ending AIDS among people who use drugs Our theory of change

CAMBODIA S FIFTH NATIONAL AIDS SPENDING ASSESSMENT (NASA),

Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies

Globalization & its Impact on Youth Health in Asia. Cai Cai Social Affairs Officer Health and Development Section Emerging Social Issues Division

One Way Ticket to Hell for young migrant drug users in Myanmar

HIV & AIDS IN THE SAARC REGION

The outlook for hundreds of thousands adolescents is bleak.

Government of Canada Federal AIDS Initiative Milestones

SEA/AIDS/174 Distribution: General. Scaling-up HIV Prevention, Care and Treatment

M&E for Accountability & Global Progress Tracking

Projected Demand for HIV Diagnostic Tests

ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia

Asia is large and diverse. HIV/AIDS: Regional and Thailand. The Asian HIV Epidemic. Praphan Phanuphak, M.D., Ph.D.

HIV Prevention in Young People: Current Context, Opportunities and Challenges Dr. Susan Kasedde Senior Specialist, HIV Prevention UNICEF, NY

Regional Health Sector Strategy on HIV,

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

Transcription:

Estimating resource needs and gaps for harm reduction in Asia Anne Bergenstrom IHRA s 20 th International Conference 20-23 April 2009 Bangkok, Thailand 1

Context Crucial role of injecting drug use in kick starting major HIV epidemics in several countries in Asia Low coverage (2-3%) of harm reduction interventions (2006)* Resource allocation does not match the drivers of the epidemics in this region Urgent need for information on resource needs and gaps for harm reduction for a scaled-up response * USAID, PEPFAR, UNAIDS, WHO, UNICEF (2006). Coverage of selected services for HIV/AIDS prevention, care and treatment in low- and middle-income countries in 2005 2

Background Study commissioned by the United Nations Regional Task Force on Injecting Drug Use and HIV/AIDS for Asia and the Pacific (UN RTF) Quality control and oversight by a working group consisting of UN RTF members (AusAID, GFATM, WHO, UNAIDS, UNODC, civil society, technical experts) Timeframe: January- April 2009 3

Purpose of the study 1. Track and analyse, by country and region, the financial resources available for harm reduction 3. Estimate, by country and region, the funding required to implement a comprehensive package of HIV prevention, treatment and care interventions for injecting drug users 5. Provide information on the resource gap and recommendations for strategic allocation of resources including prioritisation of countries for resource allocation 4

Methodology (1) 1. Definition of the target countries based on presence of injecting drug use or opiate use South Asia Afghanistan Bangladesh India Pakistan Nepal Maldives South East Asia Cambodia China Indonesia Myanmar Malaysia Lao PDR Philippines Thailand Viet Nam 5

Methodology (2) 2. Review of size of the population and HIV prevalence 3. Assessment of the critical coverage targets and current level of coverage 4. Definition of the package of interventions and standard of services 5. Cost analysis of the interventions based on unit costs 6. Estimation of the total resource requirements = (population size) x (target coverage) x (unit cost) 7. Assessment of committed/available resources 6

Comprehensive package of interventions (WHO, UNODC, UNAIDS, 2009) 1. Needle and syringe programmes (NSPs) 2. Opioid substitution therapy (OST) and other drug dependence treatment 3. HIV testing and counselling (T & C) 4. Antiretroviral therapy (ART) 5. Prevention and treatment of sexually transmitted infections (STIs) 6. Condom programmes for IDUs and their sexual partners 7. Targeted information, education and communication (IEC) for IDUs and their sexual partners 8. Vaccination, diagnosis and treatment of viral hepatitis 9. Prevention, diagnosis and treatment of tuberculosis (TB). 7

Preliminary findings (1) IDU resource need = US$0.5 billion per year in 2009 <10% of total resource need for all interventions estimated by AIDS Commission in Asia NSP & OST = 69% ART = 20% Other = 12% Condoms, VCT, STI 11.8% ART 19.4% China accounts for around 60% of resource need Currently, resource gap for NSP & OST is ~90% of resource need NSP & OST 68.7% 8

Preliminary findings (2) IDU resource need = US$0.5 billion per year in 2009 Medicines, consumables = 37% Workforce = 30% Mgt, enabling environment =16% Technical assistance = 10% Health Workforce 30% Operations 5% Equipment & Infrastructure 2% Technical Assistance 10% Mgt, Enabling, M&E, Other 16% Meds & Consumables 37% Hep C and TB prevention and treatment are not included in package of essential interventions. Inclusion would significantly increase cost. 9

Preliminary findings (3) Scaling up NSP, OST, other prevention & ART to universal coverage by 2015 Total 7-year costs = >$2 billion Benefits from reduced demand for ART and other services not evident until after 2015 (lag between infection and AIDS) $US million 10

Limitations of the study Quality of data on IDU population size and current levels of intervention coverage Limited availability of information and data on unit costs Lack of disaggregated data on current resource flows for IDU interventions as a proportion of the overall HIV prevention 11

Conclusions Annual cost of ~$100 per IDU for prevention Regional resource need $0.5 billion per year 70% of resource need in 2009 associated with NSP & OST China accounts approx 60% of need in 2009 Significant resource gap of ~90% of need in 2009 12

Recommendations Additional resources required to scale up IDU interventions Advocacy should focus on essential package of interventions Importance of low cost commodities procurement Improved health sector planning for IDU activities Use of the findings to guide the development of harm reduction components of the country proposal submissions to the GFATM and other proposal submissions Use of the study findings to inform resource allocation for harm reduction by donor partners in Asia 13

Acknowledgements Researcher: Ross McLeod, Economist and Financial Analyst Study working group: Gary Lewis, Representative, UNODC Regional Centre for East Asia and the Pacific J.V.R. Prasada Rao, Director, UNAIDS Regional Support Team Asia Pacific Jimmy Dorabjee, Principal Fellow, Burnet Institute Pascal Tanguay, Communications Manager, AHRN Mukta Sharma, Technical Officer, Harm Reduction, WHO SEARO Fabio Mesquita, Technical Officer, Harm Reduction HIV/AIDS and STI (HSI),WHO WPRO Rifat Atun, Director of Strategy, Policy and Performance, GFATM Elmar Vinh-Tomas Team Leader, East Asia & The Pacific, GFATM Swarup Sarkar, Asia AIDS Commission Secretariat Amala Reddy, Regional Programme Advisor, Strategic Information, UNAIDS RST Cho Kah Sin, Regional Programme Advisor, UNAIDS Regional Support Team Asia Pacific Jyoti Mehra, HIV Advisor, India, UNODC Regional Office for South Asia Sam Beever, Counsellor, Regional Programs, AusAID Anindya Chatterjee, Project Director, HAARP Anne Bergenstrom, Coordinator, UN RTF, UNODC Regional Centre for East Asia and the Pacific Special thanks to: Government staff INGO and NGO staff Christian Kroll, Global Coordinator HIV/AIDS and Gray Sattler, Regional HIV/AIDS Advisor, UNODC UNODC HIV Advisors and UNAIDS Country Coordinators 14

Special thanks The UN RTF operations, including this activity, is kindly supported by Swedish International Development Cooperation Agency (Sida) through the HR3 Project 15